Skip to main content

Advertisement

Log in

Non Cystic Fibrosis Bronchiectasis

  • Review Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Bronchiectasis is a pathological abnormality of the airways in which there is permanent dilatation and thickening of the airways. Precise incidence/prevalence in India is not known. Recent data suggests that about 1 % young children admitted in a hospital with pneumonia may develop bronchiectasis. Due to significant burden of pneumonia in young children in developing countries including India, it may be a significant problem that is possibly under recognized. Causes of bronchiectasis depend on the burden of respiratory infections and availability of the investigations for identification of the underlying cause. Post infectious causes are common in countries where infections are more common; however, since these countries are usually resource constrained and therefore, are not able to appropriately diagnose the other causes, leading to more than real overrepresentation of infections as a cause. In countries with less of infectious illnesses and good diagnostic facilities, malformations of airways, immune deficiency disorders and primary ciliary dyskinesia are common causes of bronchiectasis. High resolution CT scan of chest confirms the diagnosis. Treatment is supportive care and consists of maintenance of nutrition, airway clearance and antibiotics for exacerbations. Medical treatment is successful in the majority.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Roberts HJ, Hubbard R. Trends in bronchiectasis mortality in England and Wales. Respir Med. 2010;104:e981–5.

    Article  Google Scholar 

  2. Metcalfe TR, Edwards E, Byrnes C. New Zealand national incidence of bronchiectasis “too high” for a developed country. Arch Dis Child. 2005;90:737–40.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Chang AB, Bell SC, Torzillo PJ, et al; Extended Voting Group. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Med J Aust. 2015;202:130.

  4. Edmond K, Scott S, Korczak V, et al. Long term sequelae from childhood pneumonia; systematic review and meta-analysis. PLoS One. 2012;7:e31239.

  5. Rudan I, O'Brien KL, Nair H, et al; Child Health Epidemiology Reference Group (CHERG). epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health. 2013;3:010401.

  6. Angrill J, Agusti C, De Celis R, et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med. 2001;164:1628–32.

    Article  CAS  PubMed  Google Scholar 

  7. Loukides S, Bouros D, Papatheodorou G, Lachanis S, Panagou P, Siafakas NM. Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest. 2002;121:81–7.

    Article  CAS  PubMed  Google Scholar 

  8. Watt AP, Brown V, Courtney J, et al. Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis. Thorax. 2004;59:231–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Verhagen LM, de Groot R. Recurrent, protracted and persistent lower respiratory tract infection: a neglected clinical entity. J Infect. 2015;71:S106–11.

    Article  PubMed  Google Scholar 

  10. Li AM, Sonnappa S, Lex C, et al. Non-CF bronchiectasis: does knowing the aetiology lead to changes in management? Eur Respir J. 2005;26:8–14.

    Article  PubMed  Google Scholar 

  11. Karakoc GB, Yilmaz M, Altintas DU, Kendirli SG. Bronchiectasis: still a problem. Pediatr Pulmonol. 2001;32:175–8.

    Article  CAS  PubMed  Google Scholar 

  12. Eastham KM, Fall AJ, Mitchell L, Spencer DA. Paediatric lung disease: the need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax. 2004;59:324–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Nikolaizik WH, Warner JO. Aetiology of chronic suppurative lung disease. Arch Dis Child. 1994;70:141–2.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E. Non-cystic fibrosis bronchiectasis in children: a persisting problem in developing countries. Respiration. 2005;72:233–8.

    Article  CAS  PubMed  Google Scholar 

  15. Kumar A, Lodha R, Kumar P, Kabra SK. Non-cystic fibrosis bronchiectasis in children: clinical profile, etiology and outcome. Indian Pediatr. 2015;52:35–7.

    Article  PubMed  Google Scholar 

  16. Hill AT, Pasteur M, Cornford C, Welham S, Bilton D. Primary care summary of the British thoracic society guideline on the management of non-cystic fibrosis bronchiectasis. Prim Care Respir J. 2011;20:135–40.

    Article  PubMed  Google Scholar 

  17. Swensen SJ, Aughenbaugh GL, Brown LR. High-resolution computed tomography of the lung. Mayo Clin Proc. 1989;64:1284–94.

    Article  CAS  PubMed  Google Scholar 

  18. Kuhn JP, Brody AS. High-resolution CT of pediatric lung disease. Radiol Clin N Am. 2002;40:89–110.

    Article  PubMed  Google Scholar 

  19. Barker AF. Medical progress: bronchiectasis. N Engl J Med. 2002;346:1383–93.

    Article  PubMed  Google Scholar 

  20. Kang EY, Miller RR, Muller NL. Bronchiectasis: comparison of preoperative thin-section CT and pathologic findings in resected specimens. Radiology. 1995;195:649–54.

    Article  CAS  PubMed  Google Scholar 

  21. Mansour Y, Beck R, Danino J, Bentur L. Resolution of severe bronchiectasis after removal of long-standing retained foreign body. Pediatr Pulmonol. 1998;25:130–2.

    Article  CAS  PubMed  Google Scholar 

  22. Karakoç F, Karadağ B, Akbenlioğlu C, et al. Foreign body aspiration: what is the outcome? Pediatr Pulmonol. 2002;34:30–6.

    Article  PubMed  Google Scholar 

  23. Gaillard EA, Carty H, Heaf D, Smyth RL. Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs. Eur J Radiol. 2003;47:215–20.

    Article  CAS  PubMed  Google Scholar 

  24. Spencer DA. From hemp seed and porcupine quill to HRCT: advances in the diagnosis and epidemiology of bronchiectasis. Arch Dis Child. 2005;90:712–4.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Montella S, Maglione M, Bruzzese D, et al. Magnetic resonance imaging is an accurate and reliable method to evaluate non-cystic fibrosis paediatric lung disease. Respirology. 2012;17:87–91.

    Article  PubMed  Google Scholar 

  26. Kabra SK, Lodha R, Ramesh P, Sarthi M. Fiberoptic bronchoscopy in children an audit from a tertiary care center. Indian Pediatr. 2008;45:917–9.

    CAS  PubMed  Google Scholar 

  27. Kabra SK, Kabra M, Lodha R, Shastri S. Cystic fibrosis in India. Pediatr Pulmonol. 2007;42:1087–94.

    Article  CAS  PubMed  Google Scholar 

  28. Popatia R, Haver K, Casey A. Primary ciliary dyskinesia: an update on new diagnostic modalities and review of the literature. Pediatr Allergy Immunol Pulmonol. 2014;27:51–9.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Werner C, Onnebrink JG, Omran H. Diagnosis and management of primary ciliary dyskinesia. Cilia. 2015;4:2.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Agarwal R, Chakrabarti A, Shah A, et al; ABPA complicating asthma ISHAM working group. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013;43:850–73.

    Article  CAS  PubMed  Google Scholar 

  31. Welsh EJ, Evans DJ, Fowler SJ, Spencer S. Interventions for bronchiectasis: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2015;7:CD010337. [Epub ahead of print]

  32. Snijders D, Fernandez Dominguez B, Calgaro S, et al. Mucociliary clearance techniques for treating non-cystic fibrosis bronchiectasis: is there evidence? Int J Immunopathol Pharmacol. 2015;28:150–9.

  33. Bothra M, Lodha R, Kabra SK. Tobramycin for the treatment of bacterial pneumonia in children. Expert Opin Pharmacother. 2012;13:565–71.

    Article  CAS  PubMed  Google Scholar 

  34. Kuruvilla M, de la Morena MT. Antibiotic prophylaxis in primary immune deficiency disorders. J Allergy Clin Immunol Pract. 2013;1:573–82.

    Article  PubMed  Google Scholar 

  35. Serisier DJ, Martin ML. Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations. Respir Med. 2011;105:946–9.

    Article  CAS  PubMed  Google Scholar 

  36. Anwar GA, Bourke SC, Afolabi G, Middleton P, Ward C, Rutherford RM. Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. Respir Med. 2008;102:1494–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Contributions

AKG: Involved in literature search, manuscript writing; RL: Involved in manuscript writing; SKK: Involved in literature search, manuscript writing and will act as guarantor for manuscript.

Conflict of Interest

None.

Source of Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sushil K. Kabra.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gupta, A.K., Lodha, R. & Kabra, S.K. Non Cystic Fibrosis Bronchiectasis. Indian J Pediatr 82, 938–944 (2015). https://doi.org/10.1007/s12098-015-1866-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-015-1866-4

Keywords

Navigation